ESSA Pharma Inc. — Director's Dealing 2023

Jan 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2022-12-14

Reporting Person: BERGER FRANKLIN M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-14	Common Shares	S	25000	$3.00	Disposed	932244	Direct
2022-12-15	Common Shares	S	32000	$2.90	Disposed	900244	Direct
2022-12-15	Common Shares	S	50000	$2.86	Disposed	850244	Direct
2022-12-16	Common Shares	S	50000	$2.67	Disposed	800244	Direct
2022-12-20	Common Shares	S	43617	$2.53	Disposed	756627	Direct
2022-12-21	Common Shares	S	37889	$2.41	Disposed	718738	Direct
2022-12-21	Common Shares	S	34334	$2.42	Disposed	684404	Direct